Universe Pharmaceuticals INC Income Statement

Income Statement Sep2019 Sep2020 Sep2021 Sep2022 Sep2023 Sep2024
Revenue & cost
Revenue 33.23M30.70M47.98M40.14M32.31M23.02M
Cost of Revenue 19.82M16.61M22.66M19.08M21.99M16.95M
Gross Profit 13.41M14.09M25.33M21.89M10.32M6.07M
Operating items
Research & Development 0.62M0.58M5.47M7.64M4.86M3.03M
Selling, General & Administrative 1.46M1.70M3.30M2.18M2.64M2.89M
Other Operating Expenses 0.00M-0.05M-0.08M0.05M-0.24M8.17M
Operating Expenses 3.65M3.84M11.74M28.91M14.28M14.09M
Operating Income 9.75M10.25M13.59M-7.02M-3.97M-8.02M
EBIT 9.75M10.25M13.59M-7.02M-3.97M-8.02M
Non-operating items
Interest & Investment Income 0.24M-0.47M0.04M
Other Non Operating Income -0.10M-0.15M0.09M0.05M-0.24M0.15M
Non Operating Income -0.10M-0.15M0.09M-0.07M-0.36M0.15M
Net income details
EBT 9.65M10.10M13.68M-7.09M-4.33M-8.12M
Tax Provisions 2.14M2.55M3.03M1.36M2.25M0.61M
Profit After Tax 7.55M7.56M11.32M-7.91M-6.58M-8.73M
Equity Income 0.03M0.02M0.03M0.04M0.03M0.03M
Investment Income -0.04M0.03M
Income from Continuing Operations 7.51M7.55M10.65M-8.45M-6.58M-8.73M
Consolidated Net Income 7.51M7.55M10.65M-8.45M-6.58M-8.73M
Income towards Parent Company 7.51M7.55M10.65M-8.45M-6.58M-8.73M
Net Income towards Common Stockholders 7.51M7.55M10.65M-8.45M-6.58M-8.73M
Additional items
EPS (Basic) 0.470.473.58-0.00M-0.00M-626.96
EPS (Weighted Average and Diluted) 28.80M70.14M-0.00M-0.00M-626.96
Shares Outstanding (Weighted Average) 0.01M0.01M0.01M0.01M0.01M
EBITDA 6.91M8.42M12.51M-11.66M-7.36M-7.47M
Interest Expenses 0.13M0.12M0.10M0.16M0.16M0.28M
Tax Rate 22.18%25.27%22.13%